The American Diabetes Association (ADA), Boys & Girls Club of Snohomish County (BGCSC) and the Cliff Avril Family Foundation ...

Age, race, income level, obesity, and physical inactivity all contribute to the risk of being diagnosed with diabetes.

SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia, and Parkinson’s disease, ...

Type 2 diabetes is a chronic condition where the body either doesn’t produce enough insulin or doesn’t use it effectively, ...

The black marks on the neck should not be ignored, as they can be one of the earliest signs of insulin resistance and a ...

The incidence rate of heart failure was 2- to 3-fold higher among American Indian populations than rates observed in studies ...

Advances in AI have allowed researchers to use a short audio clip to detect diabetes with 66 percent accuracy in women and 71 ...

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

SGLT2 inhibitors are associated with a 20% reduced risk of Alzheimer’s disease or Parkinson’s disease, and a 30% reduced risk ...

New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.